Testing effectiveness (Phase 2)Ended earlyNCT00101621
What this trial is testing
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
Who this might be right for
CancerPain
MetaPhore Pharmaceuticals 24